Risk model for distal gastrectomy when treating gastric cancer on the basis of data from 33,917 Japanese patients collected using a nationwide web-based data entry system

Annals of Surgery

Volumn 262, Issue 2, 2015, Pages 295-303

  Kurita, Nobuhiro ^a   Miyata, Hiroaki ^a,b   Gotoh, Mitsukazu ^a,b   Shimada, Mitsuo ^a   Imura, Satoru ^a   Kimura, Wataru ^a   Tomita, Naohiro ^a   Baba, Hideo ^a   Kitagawa, Yukou ^a   Sugihara, Kenichi ^a   Mori, Masaki ^a  

^a National Clinical Database Data Quality Management Subcommittee   (Japan)

^b National Clinical Database   (Japan)

Author keywords

distal gastrectomy; gastric cancer; National Clinical Database; risk model of mortality; surgical outcome

Indexed keywords

ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CORTICOSTEROID; CREATININE; SERUM ALBUMIN; SODIUM ION;

ADULT; AGE; ALBUMIN BLOOD LEVEL; ALCOHOL CONSUMPTION; ALKALINE PHOSPHATASE BLOOD LEVEL; ANASTOMOSIS LEAKAGE; ANEMIA; ARTICLE; ASCITES; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLEEDING DISORDER; CANCER SURGERY; CREATININE BLOOD LEVEL; DAILY LIFE ACTIVITY; DISSEMINATED CANCER; EMERGENCY SURGERY; FEMALE; GASTRECTOMY; HEART INFARCTION; HUMAN; JAPANESE (PEOPLE); LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MORBIDITY; PANCREAS FISTULA; PARTIAL THROMBOPLASTIN TIME; PNEUMONIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTHROMBIN TIME; RESPIRATORY DISTRESS; RISK ASSESSMENT; SODIUM BLOOD LEVEL; STOMACH CANCER; SURGICAL INFECTION; SURGICAL MORTALITY; THROMBOCYTE COUNT; TREATMENT OUTCOME; WEIGHT REDUCTION; ADVERSE EFFECTS; AGED; EPIDEMIOLOGY; HEALTH CARE QUALITY; INTERNET; JAPAN; LAPAROSCOPY; MIDDLE AGED; MORTALITY; PATHOLOGY; RISK; RISK FACTOR; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; STOMACH NEOPLASMS; SURVIVAL RATE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; FEMALE; GASTRECTOMY; HOSPITAL MORTALITY; HUMANS; INTERNET; JAPAN; LAPAROSCOPY; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; QUALITY INDICATORS, HEALTH CARE; RISK FACTORS; SENSITIVITY AND SPECIFICITY; STOMACH NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84938266816     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000001127     Document Type: Article

References (36)

1. Siegel R, Naishadham D, Jemal A,. Cancer statistics, 2012. CA Cancer J Clin. 2012; 62: 10-29
2. Ferlay J, Shin HR, Bray F, Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917
3. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011; 14: 113-123
4. Sasako M,. Risk factors for surgical treatment in the Dutch Gastric Cancer Trial. Br J Surg. 1997; 84: 1567-1571
5. Nashimoto A, Akazawa K, Isobe Y, Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA Nationwide Registry. Gastric Cancer. 2013; 16: 1-27
6. Suzuki H, Gotoh M, Sugihara K, Nationwide survey and establishment of a clinical database for gastrointestinal surgery in Japan: Targeting integration of a cancer registration system and improving the outcome of cancer treatment. Cancer Sci. 2011; 102: 226-230
7. Songun I, Putter H, Kranenbarg EM, Surgical treatment of gastric cancer: 15-year follow-up results of the randomized nationwide Dutch D1D2 trial. Lancet Oncol. 2010; 11: 439-449
8. Cuschieri A, Fayers P, Fielding J, Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group. Lancet. 1996; 347: 995-999
9. Bonenkamp JJ, Hermans J, Sasako M, Extended lymph-node dissection for gastric cancer. N Engl J Med. 1999; 340: 908-914
10. Degiuli M, Sasako M, Ponti A, Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer. Br J Surg. 2014; 101: 23-31
11. Kimura W, Miyata H, Gotoh M, A pancreaticoduodenectomy risk model derived from 8575 cases from a national single-race population (Japanese) using a web-based data entry system: the 30-day and in-hospital mortality rates for pancreaticoduodenectomy. Ann Surg. 2014; 259: 773-780
12. Kenjo A, Miyata H, Gotoh M, Risk stratification of 7732 hepatectomy cases in 2011 from the National Clinical Database for Japan. J Am Coll Surg. 2014; 218: 412-422
13. Watanabe M, Miyata H, Gotoh M, Total gastrectomy risk model: data from 20,011 Japanese patients in a nationwide internet-based database. Ann Surg. 2014; 260: 1034-1039
14. Hall BL, Hamilton BH, Richards K, Does surgical quality improve in the American College of Surgeons National Surgical Quality Improvement Program: an evaluation of all participating hospitals. Ann Surg. 2009; 250: 363-376
15. Miyata H, Gotoh M, Hashimoto H, Challenges and prospects of a clinical database linked to the board certification system. Surg Today. 2014; 44: 1991-1999
16. Clavien PA, Barkun J, de Oliveira ML, The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009; 250: 187-196
17. Smith JK, McPhee JT, Hill JS, National outcomes after gastric resection for neoplasm. Arch Surg. 2007; 142: 387-393
18. Dhir M, Smith LM, Ullrich F, A preoperative nomogram to predict the risk of perioperative mortality following gastric resections for malignancy. J Gastrointest Surg. 2012; 16: 2026-2036
19. Oñate-Ocaña LF, Cortés-Cárdenas SA, Aiello-Crocifoglio V, Preoperative multivariate prediction of morbidity after gastrectomy for adenocarcinoma. Ann Surg Oncol. 2000; 7: 281-288
20. Grossmann EM, Longo WE, Virgo KS, Morbidity and mortality of gastrectomy for cancer in Department of Veterans Affairs Medical Centers. Surgery. 2002; 131: 484-490
21. Park DJ, Lee HJ, Kim HH, Predictors of operative morbidity and mortality in gastric cancer surgery. Br J Surg. 2005; 92: 1099-1102
22. Borja-Cacho D, Parsons HM, Habermann EB, Assessment of ACS-NSQIP's predictive ability for adverse events after major cancer surgery. Ann Surg Oncol. 2010; 17: 2274-2282
23. Ikegami N, Yoo BK, Hashimoto H, Japanese universal health coverage: evolution, achievements, and challenges. Lancet. 2011; 378: 1106-1115
24. Hashimoto H, Ikegami N, Shibuya K, Cost containment and quality of care in Japan: is there a trade-off? Lancet. 2011; 378: 1174-1182
25. Konno H, Wakabayashi G, Udagawa H, Annual Report of National Clinical Database in Gastroenterological Surgery 2011-2012. Jpn J Gastroenterol Surg. 2013; 46: 952-963
26. Wu CW, Hsiung CA, Lo SS, Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer. Br J Surg. 2004; 91: 283-287
27. Sasako M, Sano T, Yamamoto S, D2 lymphadenectomy alone or with para-Aortic nodal dissection for gastric cancer. N Engl J Med. 2008; 359: 453-462
28. Degiuli M, Sasako M, Ponti A,. Italian Gastric Cancer Study Group. Morbidity and mortality in the Italian Gastric Cancer Study Group randomized clinical trial of D1 versus D2 resection for gastric cancer. Br J Surg. 2010; 97: 643-649
29. Söreide JA, van Heerden JA, Burgart LJ, Surgical aspects of patients with adenocarcinoma of the stomach operated on for cure. Arch Surg. 1996; 131: 481-486
30. Mahar AL, Coburn NG, Singh S, A systematic review of surgery for noncurative gastric cancer. Gastric Cancer. 2012;(suppl 1): S125-S137
31. Birkmeyer JD, Siewers AE, Finlayson EV, Hospital volume and surgical mortality in the United States. N Engl J Med. 2002; 346: 1128-1137
32. Mahar AL, McLeod RS, Kiss A, A systematic review of the effect of institution and surgeon factors on surgical outcomes for gastric cancer. J Am Coll Surg. 2012; 214: 860-868
33. Degiuli M, Sasako M, Calgaro M, Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial. Eur J Surg Oncol. 2004; 30: 303-308
34. Copeland GP, Jones D, Walters M,. POSSUM: a scoring system for surgical audit. Br J Surg. 1991; 78: 355-360
35. Haga Y, Wada Y, Takeuchi H, Estimation of physiologic ability and surgical stress (E-PASS) for a surgical audit in elective digestive surgery. Surgery. 2004; 135: 586-594
36. Wang H, Chen T, Wang H, A systematic review of the Physiological and Operative Severity Score for the enUmeration of Mortality and morbidity and its Portsmouth modification as predictors of postoperative morbidity and mortality in patients undergoing pancreatic surgery. Am J Surg. 2013; 205: 466-472